Based on numerous studies, insulin resistance, obesity, and T2D have been shown to exhibit distinct alterations in the epigenome that result in the dysregulation of the key gene expression patterns involved in insulin signaling and/or lipid metabolism. This evidence concerns the gene INS and type 2 diabetes mellitus.